Trial Profile
Randomized controlled trial of Sativex to treat detrusor overactivity in multiple sclerosis.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2011
Price :
$35
*
At a glance
- Drugs Nabiximols (Primary)
- Indications Bladder dysfunction
- Focus Therapeutic Use
- 09 Mar 2011 New trial record